摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(E)-4-oxo-4-(3-(phenylcarbamoyl)-1H-indol-1-yl)but-2-enoic acid | 1213775-82-6

中文名称
——
中文别名
——
英文名称
(E)-4-oxo-4-(3-(phenylcarbamoyl)-1H-indol-1-yl)but-2-enoic acid
英文别名
N-fumaroylindole-3-carboxanilide;(E)-4-oxo-4-[3-(phenylcarbamoyl)indol-1-yl]but-2-enoic acid
(E)-4-oxo-4-(3-(phenylcarbamoyl)-1H-indol-1-yl)but-2-enoic acid化学式
CAS
1213775-82-6
化学式
C19H14N2O4
mdl
——
分子量
334.331
InChiKey
HOWRSNQZQVCBIX-ZHACJKMWSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    25
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    88.4
  • 氢给体数:
    2
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (E)-4-oxo-4-(3-(phenylcarbamoyl)-1H-indol-1-yl)but-2-enoic acid 、 (E)-N-(5-hydroxy-3-oxapentyl)-3,4-dimethoxycinnamamide 在 偶氮二甲酸二异丙酯三苯基膦 作用下, 以 四氢呋喃 为溶剂, 反应 0.67h, 以64%的产率得到(E,E)-N-[11-aza-14-(3,4-dimethoxyphenyl)-5,8-dioxa-4,12-dioxotetradeca-2,13-dienoyl]indole-3-carboxanilide
    参考文献:
    名称:
    Does conjugation of antioxidants improve their antioxidative/anti-inflammatory potential?
    摘要:
    A series of symmetric and asymmetric spermine (SPM) conjugates with all-trans-retinoic acid (ATRA), acitretin (ACI), (E)-3-(trioxsalen-4'-yl)acrylic acid (TRAA) and L-DOPA, amides of ACI, L-DOPA and TRAA with 1-aminobutane, benzylamine, dopamine and 1,12-diaminobutane as well as hybrid conjugates of O,O'-dimethylcaffeic acid (DMCA) with TRAA or N-fumaroyl-indole-3-carboxanilide (FICA) and 2-(2-aminoethoxy) ethanol were synthesized and their antioxidant properties were studied. The reducing activity (RA)% of the compounds were evaluated using the 1,1-diphenyl-2-picrylhydrazyl (DPPH) free radical-scavenging assay and found to be in the range 0-92(20 min)%/96(60 min)% at 100 mu M, the most powerful being the conjugates L-DOPA-SPM-L-DOPA (8, RA = 89%/96%) and L-DOPA-dopamine (13, RA = 92%/92%). Conjugate DMCA-NH(CH2CH2O)(2)-FICA (14) was the most powerful LOX inhibitor with IC50 33.5 mu M, followed by the conjugates ACI-NHCH2Ph (10, IC50 40.5 mu M), ACI-SPM-TRAA (7, IC50 41.5 mu M), DMCA-NH(CH2CH2O)(2)-TRAA (15, IC50 65 mu M), 13 (IC50 81.5 mu M) and ACI-dopamine (11, IC50 87 mu M). The most potent inhibitors of lipid peroxidation at 100 mu M were the conjugates 15 (98%) and ACI-SPM-ACI (4, 97%) whereas all other compounds showed activities comparable or lower than trolox. The most interesting compounds, namely ATRA-SPM-ATRA (3), 4, 10, 11 and 15, as well as unconjugated compounds such as ATRA and dopamine, were studied for their anti-inflammatory activity in vivo on rat paw oedema induced by Carrageenan and found to exhibit, for doses of 0.01 mmol/mL of conjugates per Kg of rat body weight, weaker anti-inflammatory activities (3.6-40%) than indomethacin (47%) with conjugate 3 being the most potent (40%) in this series of compounds. The cytocompatibility of selected compounds was evaluated by the viability of RAMEC cells in the presence of different concentrations (0.5-50 mu M) of the compounds. Conjugates 3 (IC50 2.6 mu M) and 4 (IC50 4.7 mu M) were more cytotoxic than the corresponding unconjugated retinoids ATRA (IC50 18.3 mu M) and ACI (IC50 14.6 mu M), whereas conjugate 15 (IC50 12.9 mu M) was less cytotoxic than either DCSP (IC50 11.3 mu M) or the tert-butyl ester of TRAA (IC50 2.9 mu M). (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2010.10.012
  • 作为产物:
    描述:
    benzhydryl (E)-4-oxo-4-(3-(phenylcarbamoyl)-1H-indol-1-yl)but-2-enoate三氟乙酸 作用下, 以 二氯甲烷 为溶剂, 反应 1.0h, 以85%的产率得到(E)-4-oxo-4-(3-(phenylcarbamoyl)-1H-indol-1-yl)but-2-enoic acid
    参考文献:
    名称:
    多烯间隔基中带有酰胺键的阿维A类似物的合成和抗氧化活性评估
    摘要:
    通过将苯胺与N-保护的吲哚-3-羧酸偶联,然后脱保护并与O-单保护的二羧酸偶联或吲哚-3-甲醛,3-乙酰基-1的Wittig反应合成抗银屑病药物阿维A酸酯的酯类似物。 -甲苯磺酰基吡咯和4-氨基-9-芴酮与Ph 3 P CHCO 2 tBu,然后在必要时进行N-脱保护,最后与肉桂酰氟偶合。通过TFA介导的羧基脱保护得到相应的游离酸。虽然这些类似物和阿维A表现出非常低的还原能力,类似物5,6,8和12强烈抑制LOX带IC 50值范围从35–65μM。阿维A和它的类似物5 - 7,10,11和15抑制脂质过氧化的比更强烈水溶性维生素E而阿维A和模拟4是在体内更有效的抗发炎剂上诱导卡拉胶比吲哚美辛的大鼠爪水肿。
    DOI:
    10.1016/j.ejmech.2009.10.012
点击查看最新优质反应信息

文献信息

  • Does conjugation of antioxidants improve their antioxidative/anti-inflammatory potential?
    作者:Dimitra Hadjipavlou-Litina、George E. Magoulas、Stavros E. Bariamis、Denis Drainas、Konstantinos Avgoustakis、Dionissios Papaioannou
    DOI:10.1016/j.bmc.2010.10.012
    日期:2010.12
    A series of symmetric and asymmetric spermine (SPM) conjugates with all-trans-retinoic acid (ATRA), acitretin (ACI), (E)-3-(trioxsalen-4'-yl)acrylic acid (TRAA) and L-DOPA, amides of ACI, L-DOPA and TRAA with 1-aminobutane, benzylamine, dopamine and 1,12-diaminobutane as well as hybrid conjugates of O,O'-dimethylcaffeic acid (DMCA) with TRAA or N-fumaroyl-indole-3-carboxanilide (FICA) and 2-(2-aminoethoxy) ethanol were synthesized and their antioxidant properties were studied. The reducing activity (RA)% of the compounds were evaluated using the 1,1-diphenyl-2-picrylhydrazyl (DPPH) free radical-scavenging assay and found to be in the range 0-92(20 min)%/96(60 min)% at 100 mu M, the most powerful being the conjugates L-DOPA-SPM-L-DOPA (8, RA = 89%/96%) and L-DOPA-dopamine (13, RA = 92%/92%). Conjugate DMCA-NH(CH2CH2O)(2)-FICA (14) was the most powerful LOX inhibitor with IC50 33.5 mu M, followed by the conjugates ACI-NHCH2Ph (10, IC50 40.5 mu M), ACI-SPM-TRAA (7, IC50 41.5 mu M), DMCA-NH(CH2CH2O)(2)-TRAA (15, IC50 65 mu M), 13 (IC50 81.5 mu M) and ACI-dopamine (11, IC50 87 mu M). The most potent inhibitors of lipid peroxidation at 100 mu M were the conjugates 15 (98%) and ACI-SPM-ACI (4, 97%) whereas all other compounds showed activities comparable or lower than trolox. The most interesting compounds, namely ATRA-SPM-ATRA (3), 4, 10, 11 and 15, as well as unconjugated compounds such as ATRA and dopamine, were studied for their anti-inflammatory activity in vivo on rat paw oedema induced by Carrageenan and found to exhibit, for doses of 0.01 mmol/mL of conjugates per Kg of rat body weight, weaker anti-inflammatory activities (3.6-40%) than indomethacin (47%) with conjugate 3 being the most potent (40%) in this series of compounds. The cytocompatibility of selected compounds was evaluated by the viability of RAMEC cells in the presence of different concentrations (0.5-50 mu M) of the compounds. Conjugates 3 (IC50 2.6 mu M) and 4 (IC50 4.7 mu M) were more cytotoxic than the corresponding unconjugated retinoids ATRA (IC50 18.3 mu M) and ACI (IC50 14.6 mu M), whereas conjugate 15 (IC50 12.9 mu M) was less cytotoxic than either DCSP (IC50 11.3 mu M) or the tert-butyl ester of TRAA (IC50 2.9 mu M). (C) 2010 Elsevier Ltd. All rights reserved.
  • Syntheses and evaluation of the antioxidant activity of acitretin analogs with amide bond(s) in the polyene spacer
    作者:Dimitra Hadjipavlou-Litina、George E. Magoulas、Marios Krokidis、Dionissios Papaioannou
    DOI:10.1016/j.ejmech.2009.10.012
    日期:2010.1
    Ester analogs of the antipsoriatic drug acitretin were synthesized by coupling either anilines with N-protected indole-3-carboxylic acid, followed by deprotection and coupling with O-monoprotected dicarboxylic acids or Wittig reaction of indole-3-carboxaldehyde, 3-acetyl-1-tosylpyrrole and 4-amino-9-fluorenone with Ph3PCHCO2tBu, followed by N-deprotection, where necessary, and finally coupling with
    通过将苯胺与N-保护的吲哚-3-羧酸偶联,然后脱保护并与O-单保护的二羧酸偶联或吲哚-3-甲醛,3-乙酰基-1的Wittig反应合成抗银屑病药物阿维A酸酯的酯类似物。 -甲苯磺酰基吡咯和4-氨基-9-芴酮与Ph 3 P CHCO 2 tBu,然后在必要时进行N-脱保护,最后与肉桂酰氟偶合。通过TFA介导的羧基脱保护得到相应的游离酸。虽然这些类似物和阿维A表现出非常低的还原能力,类似物5,6,8和12强烈抑制LOX带IC 50值范围从35–65μM。阿维A和它的类似物5 - 7,10,11和15抑制脂质过氧化的比更强烈水溶性维生素E而阿维A和模拟4是在体内更有效的抗发炎剂上诱导卡拉胶比吲哚美辛的大鼠爪水肿。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐